Pelthos Therapeutics (PTHS) Other financing activities (2025)
Pelthos Therapeutics (PTHS) posted Other financing activities of $121000.0 for Q4 2025.
Powered by 
Analysis
Pelthos Therapeutics (PTHS) Other financing activities (2025) Analysis & Trends
Pelthos Therapeutics has reported Other financing activities for 1 years, with the latest figure at $121000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 446.62 Bn | 440.05 Bn | 12.70 Bn |
| 3 | Merck | 358.24 Bn | 351.10 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.40 Bn | 260.71 Bn | 11.24 Bn |
| 5 | Pfizer | 157.04 Bn | 145.34 Bn | 10.94 Bn |
| 6 | Sanofi | 52.18 Bn | 44.80 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.98 Bn | 42.98 Bn | - |
| 8 | Incyte | 24.83 Bn | 20.30 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.38 Bn | 18.72 Bn | 683.80 Mn |
| 10 | Pelthos Therapeutics | 80.38 Mn | 55.82 Mn | 21.23 Mn |